Significant advances in assessment have been made, and proven, cost-effective treatments are widely available throughout Europe. Yet the disease remains underdiagnosed and undertreated, leaving millions of women at high risk of debilitating fractures. Given the growing number of seniors in Europe, this current model of care is shortsighted and will prove costly to health authorities. We cannot afford to ignore osteoporosis, we must act now," emphasized Judy Stenmark.